Some lungfunction studies on diffuse and bullous emphysema.

J. Bogaard,G. Nakratzas,J. Swierenga

1976-09-01

Abstract:

What problem does this paper attempt to address?

The in silico and in vitro anti-inflammatory and antibacterial activities of flavonoids from Artemisia vulgaris in Vietnam

Pham Thi Nhat Trinh,Tran Nguyen Minh An,Tong Thanh Danh,Nguyen Thi Hong Anh,Nguyen Van Kieu,Thuc-Huy Duong,Le Tien Dung

DOI: https://doi.org/10.2174/1385272827666230913105836

2023-09-13

Current Organic Chemistry

Abstract:Introduction: Artemisia vulgaris is used to treat rheumatism, scabies, and trauma-related pain in traditional Vietnamese medicine. However, there is a lack of in vitro and in silico studies on the antibacterial and anti-inflammatory effects of Artemisia vulgaris in Vietnam. Method: This research was designed to evaluate the bioactivities of extracts and isolated flavonoids from this plant. The results indicated that crude extract (AVE) and sub-fractions (hexane – AVH; ethyl acetate - AVEA; and methanol – AVM) showed a strong suppression of nitric oxide creation and proinflammatory TNF-α secretion in LPS–activated RAW 264.7 macrophages. Moreover, AVE, AVEA, and AVH demonstrated moderate antibacterial activity against Methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa strains with MICs of 2 mg/mL. Among five isolated flavonoids (1-5), apigenin (1) attenuated LPS-induced inflammation in RAW 264.7 macrophages by downregulating TNF-a and NO production, while apigenin (1) and luteolin (2) were the effective inhibitors of MRSA and P. aeruginosa strains. Result: These results are in accordance with in-silico molecular docking investigations. Among docking poses of compounds (1–5), pose 483, the best docking pose among 500 docking conformations of compound apigenin (1), has been docked to the 4WCU:PDB enzyme with the values of the binding affinity and inhibition constant of -7.27 Kcal.mol-1 and 4.73 μM, respectively and proved to be the best anti-inflammatory compound that linked well to this enzyme and was responsible for explaining anti-inflammatory activity. In silico docking to explain why luteolin (2) inhibits bacteria via a general enzyme inhibition mechanism, glucosamine-6-phosphate synthase: 2VF5. Luteolin (2) or pose 148 anchored well to 2VF5 with binding affinity and inhibition constants of -6.90 Kcal.mol-1 and 8.80 μM, respectively. Conclusion: The study demonstrated that apigenin, or pose 483, was an excellent anti-inflammatory compound with meta-hydroxy in ring B, while luteolin, or pose 148, with orto-hydroxy in ring B, exhibited good anti-bacterial activity.

chemistry, organic
[Anti-Inflammatory Material Basis and Mechanism of Artemisia Stolonifera Based on UPLC-Q-TOF-MS Combined with Network Pharmacology and Molecular Docking].

Le Chen,Yun-Yun Zhu,Li-Ping Kang,Chao-Wei Guo,Yu-Qiao Wang,Shuang-Ge Li,Hong-Zhi DU,Da-Hui Liu

DOI: https://doi.org/10.19540/j.cnki.cjcmm.20230224.201

2023-01-01

Abstract:This study aimed to explore the anti-inflammatory material basis and molecular mechanism of Artemisia stolonifera based on the analysis of the chemical components in different extracted fractions of A. stolonifera and their antioxidant and anti-inflammatory effects in combination with network pharmacology and molecular docking. Thirty-two chemical components were identified from A. stolonifera by ultra-performance liquid chromatography coupled to tandem quadrupole time-of-flight mass spectrometry(UPLC-Q-TOF-MS). Among them, there were 7, 21 and 22 compounds in water, n-butanol and ethyl acetate fractions, respectively. The antio-xidant capacity of different extracted fractions was evaluated by measuring their scavenging ability against 1,1-diphenyl-2-picrylhydrazyl radical 2,2-diphenyl-1-(2,4,6-trinitrophenyl) hydrazyl(DPPH) and 2,2'-azinobis-(3-ethylbenzthiazoline-6-sulphonic acid)(ABTS) free radicals and total antioxidant capacity [ferric reducing antioxidant power(FRAP) assay]. The inflammatory model of RAW264.7 cells was induced by lipopolysaccharide(LPS), and the levels of nitrite oxide(NO), tumor necrosis factor-α(TNF-α), interleukin-6(IL-6) in the supernatant and the mRNA expression of related inflammatory factors in cells were used to evaluate the anti-inflammatory effects. The results revealed that ethyl acetate fraction of A. stolonifera was the optimal antioxidant and anti-inflammatory fraction. By network pharmacology, it was found that flavonoids such as rhamnazin, eupatilin, jaceosidin, luteolin and nepetin could act on key targets such as TNF, serine/threonine protein kinase 1(AKT1), tumor protein p53(TP53), caspase-3(CASP3) and epidermal growth factor receptor(EGFR), and regulate the phosphatidylinositol-3-kinase-protein kinase B(PI3K-AKT) and mitogen-activated protein kinase(MAPK) signaling pathways to exert the anti-inflammatory effects. Molecular docking further indicated excellent binding properties between the above core components and core targets. This study preliminarily clarified the anti-inflammatory material basis and mechanism of ethyl acetate fraction of A. stolonifera, providing a basis for the follow-up clinical application of A. stolonifera and drug development.
Polyphenol mixture of a native Korean variety of Artemisia argyi H. (Seomae mugwort) and its anti‑inflammatory effects

Seong Min Kim,Soo Jung Lee,Venu Venkatarame Gowda Saralamma,Sang Eun Ha,Preethi Vetrivel,Kebede Taye Desta,Jin Young Choi,Won Sup Lee,Sung Chul Shin,Gon-Sup Kim

DOI: https://doi.org/10.3892/ijmm.2019.4334

Abstract:In the present study, a polyphenolic mixture was isolated from Seomae mugwort (SM; a native Korean variety of Artemisia argyi H.) via extraction with aqueous 70% methanol followed by the elution of ethyl acetate over a silica gel column. Each polyphenolic compound was analyzed using high‑performance liquid chromatography coupled with tandem mass spectrometry, and compared with the literature. In addition to the 14 characterized components, one hydroxycinnamate, six flavonoids, and one lignan were reported for the first time, to the best our knowledge, in Artemisia argyi H. The anti‑inflammatory properties of SM polyphenols were studied in lipopolysaccharide‑treated RAW 264.7 macrophage cells. The SM polyphenols attenuated the activation of macrophages via the inhibition of nitric oxide production, nuclear factor‑κB activation, the mRNA expression of inducible nitric oxide synthase, tumor necrosis factor α and interleukin‑1β, and the phosphorylation of mitogen‑activated protein kinase. Our results suggested that SM polyphenols may have therapeutic potential for the treatment of inflammatory‑related diseases.
Assessment of Polyphenols Bioaccessibility, Stability, and Antioxidant Activity of White Mugwort (Artemisia lactiflora Wall.) during Static In Vitro Gastrointestinal Digestion

Nacha Udomwasinakun,Shikha Saha,Ana-Isabel Mulet-Cabero,Peter James Wilde,Tantawan Pirak

DOI: https://doi.org/10.3390/foods12050949

IF: 5.2

2023-02-24

Foods

Abstract:White mugwort (Artemisia lactiflora Wall.), a traditional Chinese medicine, has been widely consumed in different forms for health care purposes. In this study, the in vitro digestion model of INFOGEST was used to investigate the bioaccessibility, stability, and antioxidant activity of polyphenols from two different forms of white mugwort, including dried powder (P 50, 100, and 150 mg/mL) and fresh extract (FE 5, 15, and 30 mg/mL). During digestion, the bioaccessibility of TPC and antioxidant activity were influenced by the form and ingested concentration of white mugwort. The highest bioaccessibility of the total phenolic content (TPC) and relative antioxidant activity were found at the lowest P and FE concentrations, as calculated relative to the TPC and antioxidant activity of P-MetOH and FE-MetOH based on the dry weight of the sample. Post-digestion, in comparison to P, FE had higher bioaccessibility (FE = 287.7% and P = 130.7%), relative DPPH radical scavenging activity (FE = 104.2% and P = 47.3%), and relative FRAP (FE = 673.5% and P = 66.5%). Nine compounds, 3-caffeoylquinic acid, 5-caffeoylquinic acid, 3,5-di-caffeoylquinic acid, sinapolymalate, isovitexin, kaempferol, morin, rutin, and quercetin, identified in both samples were modified during digestion, yet still provided strong antioxidant activity. These findings suggest that white mugwort extract possesses a higher polyphenol bioaccessibility, showing great potential as a functional ingredient.

food science & technology
Potent Xanthine Oxidase Inhibitory Activity of Constituents of Agastache rugosa (Fisch. and C.A.Mey.) Kuntze

Heung Joo Yuk,Hyung Won Ryu,Dong-Seon Kim

DOI: https://doi.org/10.3390/foods12030573

IF: 5.2

2023-01-28

Foods

Abstract:The aerial parts of Agastache rugosa are used as a food material and traditional medicine in Asia. A 50% ethanol extract exhibited potent xanthine oxidase (XO) inhibitory activity (IC50 = 32.4 µg/mL). To investigate the major components responsible for this effect, seven known compounds were identified from A. rugosa; among these, salvianolic acid B (2) was isolated from this plant for the first time. Moreover, acacetin (7) exhibited the most potent inhibitory activity with an IC50 value of 0.58 µM, lower than that of allopurinol (IC50 = 4.2 µM), which is commonly used as a XO inhibitor. Comparative activity screening revealed that the C6-bonded monosaccharides (3) or sugars substituted with acetyl or malonyl groups (4-6) are critical for XO inhibition when converted to aglycone (7). The most potent inhibitor (7) in the A. rugosa extract (ARE) exhibited mixed-type inhibition kinetics and reversible inhibition toward XO. Furthermore, the hydrolysis of ARE almost converted to an inhibitor (7), which displayed the highest efficacy; UPLC-qTof MS revealed an increased content, up to five times more compared with that before treatment. This study will contribute to the enhancement in the industrial value of ARE hydrolysates as a functional ingredient and natural drug toward the management of hyperuricemia and treatment of gout.
Sesquiterpenoids and Triterpenoids with Anti-Inflammatory Effects from Artemisia Vulgaris L

Tao Liu,Xiangyu Chen,Yuze Hu,Menghe H. Li,Yanting Wu,Minghui Dai,Zhilin Huang,Pinghua Sun,Junxia Zheng,Zhe Ren,Yifei Wang

DOI: https://doi.org/10.1016/j.phytochem.2022.113428

IF: 3.8

2022-01-01

Phytochemistry

Abstract:In this study, eight undescribed sesquiterpenoids (artemvulactone A-G and artemvulemdiol A), and two undescribed triterpenoids, (3S)-dammar-20,25-diene-3-hydroxy-24-one and (3S,23E)-dammar-20,23-diene-25- methoxy-3-ol were isolated from the leaves of Artemisia vulgaris L., together with ten known sesquiterpenoids and three known triterpenoids. The structures of these undescribed terpenoids were determined by extensive spectroscopy methods, including 1D and 2D-NMR, HRESIMS, IR, UV, X-ray diffraction, and ECD. The absolute configurations of artemvulactone A, artemvulactone D, and artemvulactone E were determined by X-ray diffraction (Cu Kα). All isolates were evaluated for their anti-inflammatory efficacy by detecting the expression of inflammatory mediator NO in LPS-induced RAW264.7 cells, and the results indicated that artemvulactone E exhibited significant anti-inflammatory effect with an IC50 value of 0.9 ± 0.2 μM. Furthermore, artemvulactone E could reduce LPS-induced COX-2 protein expression dose-dependently by western blotting experiments.
Comparative Analysis of Active Ingredients and Potential Bioactivities of Essential Oils from Artemisia argyi and A. verlotorum

Yun-Fen Wang,Yang Zheng,Yang Feng,Hao Chen,Shao-Xing Dai,Yifei Wang,Min Xu

DOI: https://doi.org/10.3390/molecules28093927

IF: 4.6

2023-05-07

Molecules

Abstract:Artemisia argyi H. Lév. and Vaniot is a variety of Chinese mugwort widely cultured in central China. A. verlotorum Lamotte, another variety of Chinese mugwort, has been used in the southern region of China since ancient times. Despite their similar uses in traditional medicine, little is known about the differences in their active ingredients and potential benefits. Herein, the chemical compositions of the essential oils (EOs) from both varieties were analyzed using chromatography-mass spectrometry (GC-MS). A series of databases, such as the Traditional Chinese Medicine Systems Pharmacology database (TCMSP), SuperPred database and R tool, were applied to build a networking of the EOs. Our results revealed significant differences in the chemical compositions of the two Artemisia EOs. However, we found that they shared similar ingredient–target–pathway networking with diverse bioactivities, such as neuroprotective, anti-cancer and anti-inflammatory. Furthermore, our protein connection networking analysis showed that transcription factor p65 (RELA), phosphatidylinositol 3-kinase regulatory subunit alpha (PIK3R1) and mitogen-activated protein kinase 1 (MAPK1) are crucial for the biological activity of Artemisia EOs. Our findings provided evidence for the use of A. verlotorum as Chinese mugwort in southern China.

chemistry, multidisciplinary,biochemistry & molecular biology
Anti-Hyperuricemic, Anti-Inflammatory and Analgesic Effects of Siegesbeckia orientalis L. Resulting from the Fraction with High Phenolic Content

Thuy Duong Nguyen,Phuong Thien Thuong,In Hyun Hwang,Thi Kim Huyen Hoang,Minh Khoi Nguyen,Hoang Anh Nguyen,MinKyun Na

DOI: https://doi.org/10.1186/s12906-017-1698-z

IF: 4.782

2017-04-04

BMC Complementary and Alternative Medicine

Abstract:BackgroundThe medicinal plant Siegesbeckia orientalis L. has been commonly used for the treatment of acute arthritis, rheumatism, and gout in Vietnam. However, pharmacological research of this plant associated with gout has not been reported. Anti-hyperuricemic and anti-inflammatory effects were evaluated and observed for the crude ethanol extract (CEE) of S. orientalis. Retention of these biological properties was found in a n-butanol-soluble fraction (BuOH fr.) of the extract, and therefore further biological and chemical investigations were undertaken on the BuOH fr. to support the medical relevance of this plant.MethodsThe aerial part of S. orientalis was obtained in the mountainous region of Vietnam. The crude ethanol extract (CEE) and its BuOH fr. were prepared from the plant materials. Anti-hyperuricemic activities of the CEE and BuOH fr. were tested in vivo using the model oxonate-induced hyperuricemia rats through determination of serum uric acid levels and inhibitory effects on xanthine oxidase (XO) in the rat liver. Anti-inflammatory activities of the BuOH fr. were also evaluated in vivo using carrageenan-induced paw edema and urate-induced synovitis in rats. Active components of the BuOH fr. were characterized by comparison of HPLC retention time (tR) and spectroscopic data (UV, 1H–NMR) with those of reference compounds.ResultsThe CEE of S. orientalis displayed anti-hyperuricemic activity, and the BuOH fr. was found to be the most active portion of the extract. Further in vivo studies on this fraction showed 31.4% decrease of serum uric acid levels, 32.7% inhibition of xanthine oxidase (XO), 30.4% reduction of paw edema volume, symptomatic relief in urate-induced synovitis and significant analgesic effect at the dose of 120 mg/kg, as compared to the corresponding values of the control groups. Chemical analysis of the BuOH fr. revealed high phenolic content, identified as caffeic acid analogues and flavonones.ConclusionsThis study suggested that anti-hyperuricemic and anti-inflammatory mechanism of S. orientalis is related to XO inhibitory effect of the phenolic components. Our findings support the use of this plant as the treatment of gout and other inflammatory diseases.
In vitro and in silico anti-inflammatory effect of minor constituents from the roots of Polygala arillata Buch.-Ham. ex D. Don

Bui Thi Thuy Luyen,Tran Anh Quang,Le Xuan Duy,Bui Huu Tai,Nguyen Viet Phong,Do Huu Nghi,Nguyen Minh Khoi,Nguyen Van Chinh,Nguyen Cao Cuong,Trinh Thi Thuy,Tran Thu Huong,Le Ba Vinh,Nguyen Hong Anh,Nguyen Tuan Hiep

DOI: https://doi.org/10.1080/14786419.2024.2429121

2024-11-28

Natural Product Research

Abstract:Vietnamese traditional medicine has utilised the roots of Polygala arillata Buch.-Ham. ex D. Don to treat acute arthritis, rheumatism, pain, and as a tonic ingredient. In this study, phytochemical analysis of the roots of P. arillata resulted in the isolation of one novel compound, named polygarinolide A ( 1 ), along with six known compounds ( 2 – 7 ). High-resolution electrospray ionisation mass spectrometry (HR-ESI-MS) and one- and two-dimensional nuclear magnetic resonance (NMR) spectroscopy were among the spectroscopic techniques used to identify their structures. Additionally, the absolute configuration of compound 1 was determined through ECD calculation. The NO inhibitory activity of purified substances was evaluated. Interestingly, compound 2 exhibited inhibitory activity on NO production in LPS-stimulated RAW264.7 cells (IC 50 = 25.37 μM). Moreover, interactions and binding mechanisms of the most active chemical with cyclooxygenase-2 inhibitor (COX-2) and nitric oxide synthase (iNOS) proteins were investigated by molecular docking simulations. Our findings add to our understanding of the secondary metabolites generated by P. arillata and provide a sound scientific basis for future research into the plant's potential anti-inflammatory properties.

chemistry, medicinal, applied
In Vitro Antioxidant and in Vivo Anti-Inflammatory Activities of Ophioglossum Thermale.

Xue-Qiong Zhang,Jin-Hwa Kim,Geun-Soo Lee,Hyeong-Bae Pyo,Eun-Young Shin,Eung-Gook Kim,Yong-He Zhang

DOI: https://doi.org/10.1142/s0192415x1250022x

2012-01-01

Abstract:Antioxidant fractions from Ophioglossum thermale were extracted with five different polar solvents using a Soxhlet type extractor. The total phenolic content of the extracts was determined by the Folin-Ciocalteu method. The ethyl acetate fraction of O. thermale was found to contain maximum phenolics. The dried fractions were screened for their antioxidant activity potential using in vitro model systems such as 1,1-diphenyl-2-picryl hydrazyl (DPPH), nitroblue tetrazolium (NBT) and lipid-peroxidation reduction at different concentrations. Results revealed that the EtOAc fraction exhibited the best performance in the DPPH assay, NBT assay and lipid peroxidation. All fractions showed more potent antioxidant capacity than green tea extract, a well-known antioxidant. Furthermore, the EtOAc fraction has the highest total phenolic content (475.65 mg of EGCG/g). In addition, the EtOAc fraction at 0.005% and 0.01% (g/100 ml) also significantly inhibited UVB irradiation-induced ROS generation in human dermal fibroblasts (HDFs). In a carrageenan-induced edema model, the EtOAc fraction showed an inhibitory effect (21.5%, p < 0.05) at 200 mg/kg (p.o.) after 300 min administration. Consequently, 3-O-methylquercetin (3MQ) was also isolated from the antioxidative EtOAc fraction. The data obtained using the above in vitro and in vivo tests suggest that the antioxidant activity of O. thermale and its anti-inflammatory effect on carrageenan-induced acute inflammation can be attributed to its ameliorating effect on oxidative damage, and thus it has great potential as a source for natural health products. To the best of our knowledge, this is the first report on the antioxidant activity of different polar extracts from O. thermale.
Dataset on the compounds from the leaves of Vietnamese Machilus thunbergii and their anti-inflammatory activity

Dao Cuong To,Le Minh Hoang,Hoa Thi Nguyen,Truong Thi Viet Hoa,Nhung Truong Thi Thuy,Manh Hung Tran,Phi Hung Nguyen,Phuong Dai Nguyen Nguyen,Ngu Truong Nhan,Nguyen Thi Thu Tram

DOI: https://doi.org/10.1016/j.dib.2023.109713

2023-10-22

Abstract:Machilus thunbergii has a history of traditional applications including treating dyspepsia, apoplexy, headaches, abdominal pain, abdominal distension, and leg edema [1]. It is also employed for alleviating allergies, inflammation, pain relief, promoting blood circulation, addressing costal chondritis, and sinusitis [2]. Research into the chemical composition of M. thunbergii has revealed the presence of lignans, flavonoids, lactones, and essential oils [1,[3], [4], [5]. While some investigations have explored the inhibitory effects of extracts and lignan compounds from this species on NO production [6], [7], [8], there has been no research into the flavonoids isolated from this plant and their potential for inhibiting NO production, given our reachable referencing. The ethyl acetate (EtOAc) soluble fraction of M. thunbergii leaves was subjected to column chromatography (CC) using silica gel and Sephadex LH-20 for compound isolation. Nuclear magnetic resonance (NMR) data primarily facilitated the determination of isolated compound structures. Anti-inflammatory activity was evaluated against lipopolysaccharide (LPS)-induced nitric oxide (NO) production in macrophage RAW264.7 cells. Anti-inflammatory activity-guided fractionation led to the isolation of twelve secondary metabolites (1-12). The compounds were identified as quercetin (1), kaempferol (2), rhamnetin (3), quercitrin (4), hyperoside (5), reynoutrin (6), guaijaverin (7), afzelin (8), astragalin (9), rutin (10), kaempferol-3-O-rutinoside (11), and rhamnetin-3-O-rutinoside (12). Compounds 3, 5, 6, 9, 11, and 12 were isolated from M. thunbergii for the first time. Evaluation against LPS-induced NO production in macrophage RAW264.7 cells showed that 1-3 exhibited potent inhibitory activity with IC50 values of 15.45, 25.44, and 19.82 µM, respectively. Compounds 4-9 demonstrated IC50 values ranging from 42.15 to 67.42 µM, while 10-12 exhibited inactivity (IC50 > 100 µM).
In vitro and in vivo inhibition of xanthine oxidase by the flowers of Chrysanthemum morifolium Ramat.

Teng Lit Ng,Khye Er Loh,Sheri-Ann Shu Wei Tan,Hui Yin Tan,Sze Ping Wee

DOI: https://doi.org/10.21203/rs.2.20945/v1

2020-01-15

Abstract:Abstract Background: Xanthine oxidase (XO) plays an important role in human’s purine degradation. Excessive uric acid formation results in hyperuricemia and gout. The study aimed to determine the XO inhibitory potential of Chrysanthemum morifolium Ramat. dried flower and its effect on XO gene expression in animal models. Methods: In vitro XO inhibitory assay was employed to investigate the XO inhibitory potential of C. morifolium flowers. The bioactive sub-fraction was investigated further to give additional insight on its uric acid lowering potential via animal study and XO gene expression analysis. HPLC-Q-TOF-MS/MS was utilized to identify the putative compounds in the sub-fraction. Results: Among the fractions, EtOAc fraction exhibited the highest in vitro XO inhibitory potency (51.77 ± 0.98%; IC 50 = 10.64 ± 0.51 μg/mL) and it was further fractionated into 15 sub-fractions through open column chromatography. EtOAc F7, F8, F9, F10, and F11 possessed >75% XO inhibition. F9 and F10 exhibited high in vitro XO inhibitory activity, cellular pro-proliferative effect and intracellular antioxidant activity among the sub-fractions tested. These two sub-fractions were also non-cytotoxic at the concentration range of 0.1 – 10 μg/mL. F10 was shown to be very effective in both serum and urine uric acid lowering properties in rats model upon oral consumption. It was subjected to further fractionation and a total of 11 sub-fractions were obtained. F10-4, F10-8, F10-9, and F10-10 possessed >90% XO inhibition. These sub-fractions were subjected to HPLC-Q-TOF-MS/MS analysis. A total of nine known compounds have been identified and 26 unknown compounds were detected. Conclusions : The possible mechanisms contributed to the anti-hyperuricemic effect of F10 were suggested to be non-competitive inhibition of XO enzyme, XO gene expression down regulation, and enhancement of uric acid excretion. Structure elucidation of the unknown compounds and the evaluation of the XO inhibitory activity of a single or a mixture of these compounds are recommended to identify possible synergism between them.
Identification of Anastatica hierochuntica L. Methanolic-Leaf-Extract-Derived Metabolites Exhibiting Xanthine Oxidase Inhibitory Activities: In Vitro and In Silico Approaches

Saranya Rameshbabu,Zeyad Alehaideb,Sahar S Alghamdi,Rasha S Suliman,Feras Almourfi,Syed Ali Mohamed Yacoob,Anuradha Venkataraman,Safia Messaoudi,Sabine Matou-Nasri

DOI: https://doi.org/10.3390/metabo14070368

IF: 4.1

2024-06-28

Metabolites

Abstract:There is a growing interest in the discovery of novel xanthine oxidase inhibitors for gout prevention and treatment with fewer side effects. This study aimed to identify the xanthine oxidase (XO) inhibitory potential and drug-likeness of the metabolites present in the methanolic leaf extract of Anastatica (A.) hierochuntica L. using in vitro and in silico models. The extract-derived metabolites were identified by liquid-chromatography-quadrupole-time-of-flight-mass-spectrometry (LC-QTOF-MS). Molecular docking predicted the XO inhibitory activity of the identified metabolites and validated the best scored in vitro XO inhibitory activities for experimental verification, as well as predictions of their anticancer, pharmacokinetic, and toxic properties; oral bioavailability; and endocrine disruption using SwissADMET, PASS, ProTox-II, and Endocrine Disruptome web servers. A total of 12 metabolites, with a majority of flavonoids, were identified. Rutin, quercetin, and luteolin flavonoids demonstrated the highest ranked docking scores of -12.39, -11.15, and -10.43, respectively, while the half-maximal inhibitory concentration (IC50) values of these metabolites against XO activity were 11.35 µM, 11.1 µM, and 21.58 µM, respectively. In addition, SwissADMET generated data related to the physicochemical properties and drug-likeness of the metabolites. Similarly, the PASS, ProTox-II, and Endocrine Disruptome prediction models stated the safe and potential use of these natural compounds. However, in vivo studies are necessary to support the development of the prominent and promising therapeutic use of A. hierochuntica methanolic-leaf-extract-derived metabolites as XO inhibitors for the prevention and treatment of hyperuricemic and gout patients. Furthermore, the predicted findings of the present study open a new paradigm for these extract-derived metabolites by revealing novel oncogenic targets for the potential treatment of human malignancies.
Exploring Asphodelus microcarpus as a source of xanthine oxidase inhibitors: Insights from in silico and in vitro studies

Amalia Di Petrillo,Chiara Siguri,Giovanna L. Delogu,Antonella Fais,Benedetta Era,Sonia Floris,Francesca Pintus,Amit Kumar,Massimo Claudio Fantini,Stefania Olla

DOI: https://doi.org/10.1016/j.cbi.2024.111087

IF: 5.168

2024-06-03

Chemico-Biological Interactions

Abstract:Xanthine oxidase (XO) plays a critical role in purine catabolism, catalyzing the conversion of hypoxanthine to xanthine and xanthine to uric acid, contributing to superoxide anion production. This process is implicated in various human diseases, particularly gout. Traditional XO inhibitors, such as allopurinol and febuxostat, while effective, may present side effects. Our study focuses on Asphodelus microcarpus , a plant renowned for traditional anti-inflammatory uses. Recent investigations into its phenolic-rich flowers, notably abundant in luteolin derivatives, reveal its potential as a natural source of XO inhibitors. In the present research, XO inhibition by an ethanolic flowers extract from A. microcarpus is reported. In silico docking studies have highlighted luteolin derivatives as potential XO inhibitors, and molecular dynamics support that luteolin 7- O -glucoside has the highest binding stability compared to other compounds and controls. In vitro studies confirm that luteolin 7- O -glucoside inhibits XO more effectively than the standard inhibitor allopurinol, with an IC 50 value of 4.8 μg/mL compared to 11.5 μg/mL, respectively These findings underscore the potential therapeutic significance of A. microcarpus in managing conditions related to XO activity. The research contributes valuable insights into the health-promoting properties of A. microcarpus and its potential application in natural medicine, presenting a promising avenue for further exploration in disease management.

pharmacology & pharmacy,biochemistry & molecular biology,toxicology
In vivo anti-hyperuricemia and anti-gouty arthritis effects of the ethanol extract from Amomumvillosum Lour.

Li Dong,Shanhui Zhang,Lina Chen,Jun Lu,Fuhui Zhao,Tiemei Long,Jinlan Wen,Jiayu Huang,Yuanhu Mao,Zhengfang Qi,Jiquan Zhang,Lei Li,Yongxi Dong

DOI: https://doi.org/10.1016/j.biopha.2023.114532

2023-03-16

Abstract:The incidence of hyperuricemia and gout has been increasing year by year, and it is showing a younger trend. However, the first-line drugs currently used for hyperuricemia and gouty arthritis have serious side effects that limit their clinical application. Amomum villosum Lour. has been widely used in China for thousands of years as a traditional medical and edible plant, and previous screening showed that the ethanol extract of Amomum villosum Lour. could effectively inhibit the activity of xanthine oxidase. Based on this discovery, this paper had achieved in-depth mechanism research. The results showed that the ethanol extract of Amomum villosum Lour. could treat hyperuricemia by reducing the production of uric acid via inhibition of xanthine oxidase and increasing the excretion of uric acid via regulation of urate transporters. Meanwhile, the extract also showed a certain protective effect on hepatic and renal damage caused by hyperuricemia. With the formation of extensive uric acid, gouty arthritis will be induced by the deposition of monosodium urate in the joint. The extract could also relieve the inflammation by reducing the expression of inflammatory cytokines. In conclusion, the extract deserves focused research and development as a potential medicine, health care product or supplemented food for the prevention and treatment of hyperuricemia and gouty arthritis.

pharmacology & pharmacy,medicine, research & experimental
First trimester inhibin‐A concentrations and later development of preeclampsia

E. Roes,M. Gaytant,C. Thomas,M. Raijmakers,P. Zusterzeel,W. Peters,E. Steegers

DOI: https://doi.org/10.1111/j.1600-0412.2004.00140.x

2004-01-01

Acta Obstetricia Et Gynecologica Scandinavica

Abstract:Sir, We read with interest the article by D’Anna et al. (1). In their study mid-trimester inhibin-A concentrations were not elevated among women with pregnancy-induced hypertension or preeclampsia. In contrast with D’Anna et al. we studied the possible role of inhibin-A as an early predictor of preeclampsia during the first trimester of pregnancy and not as a marker of disease. It has been suggested that increased inhibin-A serum levels in early pregnancy are associated with the development of preeclampsia and that elevated levels in the second trimester are helpful in prediction of preeclampsia (2, 3). Nineteen women destined to develop preeclampsia and/or hemolysis elevated liver enzymes low platelets (HELLP) syndrome and 36 women who remained normotensive throughout pregnancy were included. Preeclampsia was defined as a diastolic blood pressure above 90 mmHg on two occasions more than 4 h apart with proteinuria of more than 0.3 g/L. Blood was drawn by vene puncture at the first prenatal visit, between 6 and 15 weeks amenorrhea. Serum inhibin-A concentrations were determined using a commercial enzyme-linked immunosorbent assay (ELISA) kit (4). Statistical analyses to compare serum inhibin-A concentrations between the patient and the control groups were performed using Student’s t-test. A p-value below 0.05 was considered to indicate statistical significance. Subsequently, receiver-operating characteristic (ROC) analysis was performed to assess the best cut-off value and discriminating capacity of inhibin-A. Sensitivity, specificity, predictive values and likelihood ratio of a positive and negative test were calculated in order to consider the predictive efficacy of first trimester serum inhibin-A concentrations. Median (range) serum inhibin-A concentrations were significantly (p< 0.05) higher in patients compared to controls; 281 (82–2300) pg/mL vs. 234 (26–455) pg/mL, respectively. Placental protein leakage due to syncytiotrophoblast alteration might cause the elevated inhibin-A serum concentrations (5). Another possibility might be reactive hyperplasia of cytotrophoblastic cells due to reduced oxygen supply, as has been suggested for increased human chorionic gonadotropin (hCG) concentrations in early trimester of pregnant women who subsequently develop preeclampsia (6). Both proposed mechanisms are possibly present long before onset of disease. Despite the significantly higher median inhibin-A concentrations early in pregnancy of the cases, the sensitivities and predictive values of a positive and negative test for the two cut-off values were too low to provide a reliable predictor of disease (Table I). Furthermore, considering the likelihood ratio of 3.2, the capacity of increased inhibin-A concentrations as a predictive marker for developing preeclampsia appears to be low. In conclusion, our results indicate that first trimester serum inhibin-A concentration cannot be used as a single predictor for development of preeclampsia. Combination models with other biochemical and clinical markers have to be studied and future studies should also elucidate the optimal sampling time. E. M. Roes M. A. Gaytant C. M.G. Thomas M. T. M. Raijmakers P. L. M. Zusterzeel W. H. M. Peters E. A. P. Steegers
Anti-hyperuricemic bioactivity of Alstonia scholaris and its bioactive triterpenoids in vivo and in vitro

Bin-Yuan Hu,Yun-Li Zhao,Dan-Yu Ma,Mei-Ling Xiang,Li-Xing Zhao,Xiao-Dong Luo

DOI: https://doi.org/10.1016/j.jep.2022.115049

IF: 5.195

2022-05-01

Journal of Ethnopharmacology

Abstract:ETHNOPHARMACOLOGY RELEVANCE: One folk use of Alstonia scholaris (L.) R. Br. in "Dai" ethno-medicine system is to treat gouty arthritis, which might be caused by hyperuricemia, but anti-hyperuricemic investigation of A. scholaris were rarely reported.AIM OF THE STUDY: To verify anti-hyperuricemic property of A. scholaris, and explore its bioactive compounds in vivo and in vitro.MATERIALS AND METHODS: The anti-hyperuricemic bioactivity of the non-alkaloids fraction and compounds were evaluated with potassium oxonate (PO) induced hyperuricemia mice model in vivo, and monosodium urate (MSU) induced human renal tubular epithelial cells (HK-2) was selected to test in vitro, respectively, with benzobromarone as the positive control. 11 triterpenoids were isolated by phytochemical methods and their structures were elucidated by spectroscopic analysis and ECD calculation.RESULTS: The non-alkaloids fraction of A. scholaris decreased the serum uric acid (UA) level in mice model significantly at the doses of 100 mg/kg and 200 mg/kg, and then nine ursane- and two oleanane-triterpenoids including four new compounds (1-3 and 10) were isolated from the bioactive fraction, in which compounds 1, 4, 5, 6 and 10 exhibited better anti-hyperuricemic tendency in vitro by promoting the excretion of UA in MSU-induced HK-2 cell model at a concentration of 5 μM. Furthermore, compounds 1 and 4 were proved to reduce the serum UA level in mice significantly at 5 mg/kg in vivo.CONCLUSIONS: The results supported the traditional use of A. scholaris in treating gouty arthritis, and also provided new bioactive triterpenoids for further chemical and pharmacological investigation.

pharmacology & pharmacy,chemistry, medicinal,integrative & complementary medicine,plant sciences
Preliminary study on the material basis and mechanism underlying uric acid reduction by Thlaspi arvense L.

Xiumei Ke,Xuan Yang,Chao Hou,Yunhong Wang,YiFei Zhou,Tongxuan Wu,Rongping Yang

DOI: https://doi.org/10.1016/j.jep.2023.116814

IF: 5.195

2023-09-02

Journal of Ethnopharmacology

Abstract:Ethnopharmacological relevance In the Tibetan region of China, Thlaspi arvense L. is utilized for the prevention and treatment of hyperuricemia (HUA). Thlaspi arvense has been shown to lower uric acid levels in HUA rats in preliminary studies. However, the active components and mechanisms that account for its therapeutic effects remain elusive. Aim of study Network pharmacology, ultra-performance liquid chromatography-quadrupole time-of-flight tandem mass spectrometry (UPLC-Q-TOF-MS), mRNA-sequencing, and quantitative reverse transcription PCR (RT-PCR) were used to investigate the active ingredients of Thlaspi arvense against HUA in rats and elucidate the underlying mechanisms in this study. Materials and methods A HUA rat model was established by a combination of intraperitoneal injection of potassium oxonate and intragastric administration of yeast extract. In the control and model groups, gastric gavage was performed to administer a normal saline solution, 4.5 mg kg −1 benzbromarone in the positive drug group, and 3.5 g kg −1 Thlaspi arvense in the Thlaspi arvense group. After which network pharmacology and UPLC-Q-TOF-MS were employed to explore the active ingredients underlying the lowering of uric acid in Thlaspi arvense . In addition, mRNA-sequencing, network pharmacology and RT-PCR were applied to uncover Thlaspi arvense 's mechanism of uric acid reduction. Results The results showed that a two-week administration of the effective constituents of Thlaspi arvense led to a significant improvement in HUA rats, including lower serum levels of uric acid (UA), xanthine oxidase (XOD), creatinine (CREA), carbamide (UREA), aspartate aminotransferase (AST), alanine transaminase (ALT), and liver tissue activities of XOD, ADA, super (MDA). A network pharmacological analysis revealed 40 active compounds, including organic acids and flavonoids , that act on HUA therapeutic targets. These targets primarily focus on pathways related to uric acid metabolism modulation, such as XOD, SLC22A12, ABCG2, SLC22A8, and others, reducing HUA. The analysis of mRNA-sequencing as well as RT-PCR data from renal tissue demonstrated that the targets modulating uric acid metabolism were SLC22A8, SLC12A1, and SLC16A7. Conclusion In summary, organic acids and flavonoids may be the active components in Thlaspi arvense that alleviate HUA. The principal mechanisms are as follows: inhibition of XOD activity in the serum to reduce uric acid production, regulation of renal reabsorption and secretion of uric acid to increase uric acid excretion, and alleviation of oxidative stress reaction to decrease systemic damage and, eventually, treatment of HUA.

pharmacology & pharmacy,chemistry, medicinal,integrative & complementary medicine,plant sciences
Gastroprotective effect and in vitro Antioxidant Activities of the Aqueous Extract from Artemisia absinthium L Aerial Parts

Chahrazed KAOUDOUNE,Fatima Benchikh,Hassiba Benabdallah,Karima Loucif,Soulaf Mehlous,Smain Amira

DOI: https://doi.org/10.22270/jddt.v10i4.4253

2020-07-15

Journal of Drug Delivery and Therapeutics

Abstract:Artemisia absinthium L. is a medicinal plant largely used in traditional medicine. The aim of this study was to estimate the content of polyphenols, and flavonoids compounds and also to evaluate the antioxidant and the anti-ulcer activities of the Aqueous extract from Artemisia absinthium L. aerial parts. The Folin-Ciocalteau and AlCl3 methods were applied in order to quantify the polyphenolic and flavonoids contents, respectively. However, DPPH method was used to evaluate the in vitro antioxidant activity. Quantitative analysis of the yield and phenolic content of the aqueous extract of Artemisia absinthium showed that the yield of the aqueous extract was 19.32% and its phenolic content was 58.66 ± 2.16 μg GAE / mg dry extract for polyphenols and 6.85 μg QE / mg dry extract for the flavonoids. The antioxidant activity of the plant extract evaluated by the DPPH test is very important (IC50=45.48±0.37 μg/ml). Treatment of mice with the aqueous extract of Artemisia absinthium at a dose of 400 mg / kg significantly reduced the ulcerogenic effect of ethanol on the gastric wall with an estimated protection rate of 91%. These findings suggest that Artemisia absinthium L. aqueous extract possessed good antiulcer and antioxidant potentials. This supports the traditional claims of this plant in folklore medicine. Keywords: Artemisia absinthium, polyphenols, antioxidant activity, gastric ulcer, ethanol.
The European Organization for Research on Treatment of Cancer.

H. Tagnon

DOI: https://doi.org/10.7326/0003-4819-84-3-378_2

IF: 4.037

1986-03-01

European Journal of Surgical Oncology

Abstract:

Some lungfunction studies on diffuse and bullous emphysema.

The in silico and in vitro anti-inflammatory and antibacterial activities of flavonoids from Artemisia vulgaris in Vietnam

[Anti-Inflammatory Material Basis and Mechanism of Artemisia Stolonifera Based on UPLC-Q-TOF-MS Combined with Network Pharmacology and Molecular Docking].

Polyphenol mixture of a native Korean variety of Artemisia argyi H. (Seomae mugwort) and its anti‑inflammatory effects

Assessment of Polyphenols Bioaccessibility, Stability, and Antioxidant Activity of White Mugwort (Artemisia lactiflora Wall.) during Static In Vitro Gastrointestinal Digestion

Potent Xanthine Oxidase Inhibitory Activity of Constituents of Agastache rugosa (Fisch. and C.A.Mey.) Kuntze

Sesquiterpenoids and Triterpenoids with Anti-Inflammatory Effects from Artemisia Vulgaris L

Comparative Analysis of Active Ingredients and Potential Bioactivities of Essential Oils from Artemisia argyi and A. verlotorum

Anti-Hyperuricemic, Anti-Inflammatory and Analgesic Effects of Siegesbeckia orientalis L. Resulting from the Fraction with High Phenolic Content

In vitro and in silico anti-inflammatory effect of minor constituents from the roots of Polygala arillata Buch.-Ham. ex D. Don

In Vitro Antioxidant and in Vivo Anti-Inflammatory Activities of Ophioglossum Thermale.

Dataset on the compounds from the leaves of Vietnamese Machilus thunbergii and their anti-inflammatory activity

In vitro and in vivo inhibition of xanthine oxidase by the flowers of Chrysanthemum morifolium Ramat.

Identification of Anastatica hierochuntica L. Methanolic-Leaf-Extract-Derived Metabolites Exhibiting Xanthine Oxidase Inhibitory Activities: In Vitro and In Silico Approaches

Exploring Asphodelus microcarpus as a source of xanthine oxidase inhibitors: Insights from in silico and in vitro studies

In vivo anti-hyperuricemia and anti-gouty arthritis effects of the ethanol extract from Amomumvillosum Lour.

First trimester inhibin‐A concentrations and later development of preeclampsia

Anti-hyperuricemic bioactivity of Alstonia scholaris and its bioactive triterpenoids in vivo and in vitro

Preliminary study on the material basis and mechanism underlying uric acid reduction by Thlaspi arvense L.

Gastroprotective effect and in vitro Antioxidant Activities of the Aqueous Extract from Artemisia absinthium L Aerial Parts

The European Organization for Research on Treatment of Cancer.